14:02:24 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-30 Kvartalsrapport 2024-Q2
2024-05-27 Ordinarie utdelning OBSRV 0.00 NOK
2024-05-24 Årsstämma 2024
2024-03-13 Bokslutskommuniké 2023
2023-11-22 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-30 Ordinarie utdelning OBSRV 0.00 NOK
2023-05-26 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Årsstämma 2022
2022-06-03 Kvartalsrapport 2022-Q1
2022-06-03 Ordinarie utdelning OBSRV 0.00 NOK
2022-03-29 Bokslutskommuniké 2021
2022-02-04 Extra Bolagsstämma 2022
2021-11-03 Kvartalsrapport 2021-Q3
2021-08-20 Kvartalsrapport 2021-Q2
2021-05-25 Ordinarie utdelning OBSRV 0.00 NOK
2021-05-21 Årsstämma 2021
2021-05-12 Kvartalsrapport 2021-Q1
2021-02-23 Bokslutskommuniké 2020
2020-11-03 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning OBSRV 0.00 NOK
2020-06-30 Årsstämma 2020
2020-06-16 Extra Bolagsstämma 2020
2020-05-12 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriMedicinteknik
Observe Medical är ett norskt bolag verksamma inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo, Norge.
2021-02-12 08:57:49
Oslo February 12, 2021 - Observe Medical ASA (OSE: OBSERV), announces that a
major hospital in Northern Italy has equipped the ICU department with Sippi®
systems in clinical use, the result of the close collaboration with Observe
Medical distributor in Italy, SIM Italia.

As a result of the strengthened partnership in 2020 with the distributor SIM
Italia and the subsequent close collaboration to prepare the launch of Sippi®, a
major hospital in Northern Italy has now installed Sippi® systems in clinical
use at the ICU department.

"We are pleased to announce that our close collaboration with SIM Italia for the
important Italian market has now resulted in the installation and clinical use
of Sippi® at the ICU department in a major hospital in northern Italy," says
Björn Larsson, CEO Observe Medical.

"SIM Italia is a well-established, committed and professional partner with
strong customer relations, which is essential to get customer access during the
ongoing pandemics which has had severe implications on the healthcare system in
Italy as in other regions. This recent installation of Sippi® in the ICU
department, may serve as a reference for other departments at the same hospital
as well as at other hospitals," concludes Björn Larsson, CEO of Observe Medical.

Observe Medical is currently launching Sippi® automated digital urine meter with
the short-term focus of accelerating the clinical use of Sippi® in the Nordics
and selected markets in Europe.

For further information, please contact:

Observe Medical: Björn Larsson, CEO, +46 76 620 17 25,
bjorn.larsson@observemedical.com

About Observe Medical

https://observemedical.com/ Observe Medical develops, markets, and sells
innovative hospital products that contribute to increased patient safety and a
more efficient care system. The company's ambition is to drive growth by
leveraging its expertise in sales and commercialization of its broad portfolio
of medical technology products, mainly in the areas of Urine measurement,
Anesthesiology/ICUs, and wound care, in combination with targeted M&A. The
company's headquarter is in Oslo, Norway and its operations are based out of
Gothenburg, Sweden. Observe Medical has a direct sales organization in the
Nordics and a distributor network internationally. Observe Medical's product,
Sippi®, is the only automated digital urine meter with the possibility for
wireless data transfer to hospital patient data management systems and hinders
bacterial migration that can lead to urinary infections (Sippcoat®). Sippi® is
CE marked and currently being launched with a focus on selected markets and
hospitals in the Nordics and in Europe.

About SIM Italia S.r.l.

https://www.simitalia.it/en Founded in 1979 by a group of managers dedicated to
international medical marketing, SIM Italia S.r.l. has grown progressively in
its field, to manage an ever larger variety of products and affirming itself as
one of the most well-known Italian import/export companies on the Italian
market. The success of the company was due to the positive response of SIM
Italia's distributive policy on the part of an ever larger group of qualified
and well introduced local authorized retailers, who through an original form of
strategic symbiosis, are delegated the distribution of the products. The
products that SIM Italia represents exclusively in Italy are principally medical
devices and single use disposable products